
|
|  | |
|
Am J Psychiatry 1994; 151:1372-1374
Copyright © 1994 by American Psychiatric Association
Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study
M Fava, JF Rosenbaum, PJ McGrath, JW Stewart, JD Amsterdam and FM Quitkin
Clinical Psychopharmacology Unit, Massachusetts General Hospital, Boston 02114.
Forty-one patients who had failed to respond to 8 weeks of treatment with
20 mg of fluoxetine were randomly assigned to one of three treatments for 4
weeks: 40-60 mg/day of fluoxetine, 20 mg/day of fluoxetine plus 25-50
mg/day of desipramine, and 20 mg/day of fluoxetine plus 300-600 mg/day of
lithium. Patients treated with high- dose fluoxetine (N = 15) did
significantly better than patients treated with fluoxetine plus lithium (N
= 14) and those treated with fluoxetine plus desipramine (N = 12).
High-dose fluoxetine was the most effective treatment among partial
responders to previous treatment, but high-dose fluoxetine and fluoxetine
plus lithium were the most effective treatments among nonresponders.
This article has been cited by other articles:

|
 |

|
 |
 
I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al.
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
J Psychopharmacol,
June 1, 2008;
22(4):
343 - 396.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. G. RUHE, J. HUYSER, J. A. SWINKELS, and A. H. SCHENE
Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorder: Systematic review
The British Journal of Psychiatry,
October 1, 2006;
189(4):
309 - 316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Cowen
New drugs, old problems: REVISITING... PHARMACOLOGICAL MANAGEMENT OF TREATMENT-RESISTANT DEPRESSION
Advan. Psychiatr. Treat.,
January 1, 2005;
11(1):
19 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. L. MOVIG, R. BAUMGARTEN, H. G. M. LEUFKENS, J. H. M. VAN LAARHOVEN, and A. C. G. EGBERTS
Risk factors for the development of lithium-induced polyuria
The British Journal of Psychiatry,
April 1, 2003;
182(4):
319 - 323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. STIMPSON, N. AGRAWAL, and G. LEWIS
Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression: Systematic review
The British Journal of Psychiatry,
October 1, 2002;
181(4):
284 - 294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Thase, A. J. Rush, R. H. Howland, S. G. Kornstein, J. H. Kocsis, A. J. Gelenberg, A. F. Schatzberg, L. M. Koran, M. B. Keller, J. M. Russell, et al.
Double-blind Switch Study of Imipramine or Sertraline Treatment of Antidepressant-Resistant Chronic Depression
Arch Gen Psychiatry,
March 1, 2002;
59(3):
233 - 239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Stein, D. W. Black, N. A. Shapira, and R. L. Spitzer
Hypersexual Disorder and Preoccupation With Internet Pornography
Am J Psychiatry,
October 1, 2001;
158(10):
1590 - 1594.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. D. Glick, T. Suppes, C. DeBattista, R. J. Hu, and S. Marder
Psychopharmacologic Treatment Strategies for Depression, Bipolar Disorder, and Schizophrenia
Ann Intern Med,
January 2, 2001;
134(1):
47 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 1994
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|